<i>Lactobacillus reuteri</i> Colonisation of Extremely Preterm Infants in a Randomised Placebo-Controlled Trial

<i>Lactobacillus reuteri</i> Colonisation of Extremely Preterm Infants in a Randomised Placebo-Controlled Trial

<i>Lactobacillus reuteri</i> DSM 17938 supplementation reduces morbidities in very low birth weight infants (<1500 g), while the effect on extremely low birth weight infants (ELBW, <1000 g) is still questioned. In a randomised placebo-controlled trial (ClinicalTrials.gov ID NCT0160...

Full description

Bibliographic Details
Main Authors: Johanne E. Spreckels, Erik Wejryd, Giovanna Marchini, Baldvin Jonsson, Dylan H. de Vries, Maria C. Jenmalm, Eva Landberg, Eva Sverremark-Ekström, Magalí Martí, Thomas Abrahamsson
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Microorganisms
Subjects:
antibiotic
extremely low birth weight
feeding intolerance
human milk oligosaccharide
<i>Lactobacillus reuteri</i>
premature
Online Access:https://www.mdpi.com/2076-2607/9/5/915

Internet

https://www.mdpi.com/2076-2607/9/5/915

Similar Items